Literature DB >> 17906186

Short-term supplementation with plant extracts rich in flavonoids protect nigrostriatal dopaminergic neurons in a rat model of Parkinson's disease.

Krishna P Datla1, Virginia Zbarsky, Deepal Rai, Shabnam Parkar, Naomi Osakabe, Okezie I Aruoma, David T Dexter.   

Abstract

OBJECTIVE: Antioxidants from plants were known to reduce the oxidative stress by scavenging free radicals, chelating metal ions and reducing inflammation. As increased oxidative stress was implicated in the nigrostriatal dopaminergic neuronal loss in Parkinson's disease (PD), we have assessed whether the plant extracts protects the nigrostriatal dopaminergic neurons in the animal model of PD.
METHODS: Male adult Sprague-Dawley rats were treated orally between 10 am-11 am each day with the extracts from tangerine peel, grape seeds, cocoa and red clover for four days. One hour after the final dosing, the left medial forebrain bundle was lesioned by infusing the dopaminergic neurotoxin 6-hydroxydopamine (6-OHDA; 12 microg) under anaesthesia. Seven days post-lesion, the number of dopaminergic cells in the substantia nigra pars compacta and the levels of dopamine and its metabolites 3, 4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the striata were quantified and compared with the vehicle-treated groups.
RESULTS: Compared to the unlesioned side, 6-OHDA lesions significantly reduced the number of dopaminergic cells and the levels of dopamine and its metabolites DOPAC and HVA in the vehicle-treated animals. Pretreatment of animals with extracts of tangerine peel (rich in polymethoxylated flavones; 35 mg/kg/day), cocoa-2 (rich in procyanidins; 100 mg/kg/day) and red clover (rich in isoflavones; 200 mg/kg/day) significantly attenuated the 6-OHDA-induced dopaminergic loss. However, no significant protection was seen in animals supplemented with red and white grape seeds (rich in catechins; 100 mg/kg/day), and cocoa-1 (rich in catechins; 100 mg/kg/day).
CONCLUSIONS: Pre-treatment of plant extracts rich in polymethoxylated flavones, procyanidins and isoflavones but not catechins protected the nigrostriatal dopaminergic neurons in the rat model of PD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17906186     DOI: 10.1080/07315724.2007.10719621

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  12 in total

1.  The neuroprotective potential of sinapic acid in the 6-hydroxydopamine-induced hemi-parkinsonian rat.

Authors:  Kobra Zare; Akram Eidi; Mehrdad Roghani; Ali Haeri Rohani
Journal:  Metab Brain Dis       Date:  2014-08-16       Impact factor: 3.584

2.  Neuroprotective effects of anthocyanin- and proanthocyanidin-rich extracts in cellular models of Parkinson׳s disease.

Authors:  Katherine E Strathearn; Gad G Yousef; Mary H Grace; Susan L Roy; Mitali A Tambe; Mario G Ferruzzi; Qing-Li Wu; James E Simon; Mary Ann Lila; Jean-Christophe Rochet
Journal:  Brain Res       Date:  2014-02-03       Impact factor: 3.252

3.  Multiple pharmacological actions of Yiqi Huatan Decoction in a model of depression in rats.

Authors:  Hai-Hong Zhou; Shao-Dong Chen; Yin Xu; Yong-Zhu Han; Ji-Yuan Hu
Journal:  Chin J Integr Med       Date:  2012-03-14       Impact factor: 1.978

4.  Habitual intake of dietary flavonoids and risk of Parkinson disease.

Authors:  X Gao; A Cassidy; M A Schwarzschild; E B Rimm; A Ascherio
Journal:  Neurology       Date:  2012-04-04       Impact factor: 9.910

5.  Neuroprotective effect of cocoa flavonoids on in vitro oxidative stress.

Authors:  Emma Ramiro-Puig; Gemma Casadesús; Hyoung-gon Lee; Xiongwei Zhu; Andrew McShea; George Perry; Francisco J Pérez-Cano; Mark A Smith; Margarida Castell
Journal:  Eur J Nutr       Date:  2008-11-29       Impact factor: 5.614

6.  Iron Chelators as Potential Therapeutic Agents for Parkinson's Disease.

Authors:  Carlos A Perez; Yong Tong; Maolin Guo
Journal:  Curr Bioact Compd       Date:  2008-10-01

Review 7.  Botanical phenolics and brain health.

Authors:  Albert Y Sun; Qun Wang; Agnes Simonyi; Grace Y Sun
Journal:  Neuromolecular Med       Date:  2008-11-01       Impact factor: 3.843

8.  Auraptene and Other Prenyloxyphenylpropanoids Suppress Microglial Activation and Dopaminergic Neuronal Cell Death in a Lipopolysaccharide-Induced Model of Parkinson's Disease.

Authors:  Satoshi Okuyama; Tomoki Semba; Nobuki Toyoda; Francesco Epifano; Salvatore Genovese; Serena Fiorito; Vito Alessandro Taddeo; Atsushi Sawamoto; Mitsunari Nakajima; Yoshiko Furukawa
Journal:  Int J Mol Sci       Date:  2016-10-17       Impact factor: 5.923

Review 9.  Revisiting the Medical Management of Parkinson's Disease: Levodopa versus Dopamine Agonist.

Authors:  Jinglin Zhang; Louis Chew-Seng Tan
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

10.  Berberine chloride pretreatment exhibits neuroprotective effect against 6-hydroxydopamine-induced neuronal insult in rat.

Authors:  Feraidoon Negahdar; Mehdi Mehdizadeh; Mohammad Taghi Joghataei; Mehrdad Roghani; Fereshteh Mehraeen; Ehsan Poorghayoomi
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.